Health Condition 1: M959- Acquired deformity of musculoskeletal system, unspecified
Conditions
Interventions
Intervention1: Group LD: Patients will be nebulized with dexmedetomidine 2 mcg/kg (diluted with normal saline (NS) to make a total volume of 2 mL) plus 4 ml of 4%(160mg) lignocaine (total vol. 6ml) in
Sponsors
M D M Hospital Dr S N Medical College Jodhpur
Eligibility
Inclusion criteria
Inclusion criteria: American Society of Anesthesiologists (ASA) physical status of Iâ??II, and body mass index (BMI) <=25 kg/cm2 with anticipated difficult airway will be posted for elective surgery under general anesthesia included in the study
Exclusion criteria
Exclusion criteria: a. Patient refusal b. Patients with a history of allergy to the local anesthetic or Dexmedetomidine c. Patients with nasal infection or complete obstruction d. Pregnancy (confirmed by history and card test) and lactation e. Patients with coagulation dysfunction
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the patients comfort & compliance for intubation in terms of COUGH SCORE using dexmedetomidine as an adjuvant to lignocaine for nebulization & lignocaine alone for nebulization in patients undergoing awake fiberoptic intubation.Timepoint: 1 hour | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. RAMSAY SEDATION SCORE 2. POST INTUBATION SCORE 3. The mean time to intubation 4. Hemodynamic parameters 5. Patient satisfactionTimepoint: 24 hours | — |
Countries
India
Contacts
Public ContactDr Geeta Singariya
Dr. S.N. medical collage, Jodhpur
Outcome results
None listed